Quarterly report · Q2

Period2022-04-01 → 2022-09-30
Filed2022-11-10
StandardJapan GAAP
ConsolidatedYes
Data checks14 of 14 passed
Key figures · 46
MetricValuePeriodScopeSource row
Revenue¥1.2bn2022-04-01 → 2022-09-30Cons.Net sales
Revenue¥2.4bn2021-04-01 → 2022-03-31Cons.Net sales (5-year summary)
Revenue¥1.1bn2021-04-01 → 2021-09-30Cons.Net sales
Operating income¥94m2022-04-01 → 2022-09-30Cons.Operating income
Operating income¥116m2021-04-01 → 2021-09-30Cons.Operating income
Ordinary income¥120m2022-04-01 → 2022-09-30Cons.Ordinary income
Ordinary income¥352m2021-04-01 → 2022-03-31Cons.Ordinary income loss (5-year summary)
Ordinary income¥131m2021-04-01 → 2021-09-30Cons.Ordinary income
Profit before tax¥119m2022-04-01 → 2022-09-30Cons.Income before income taxes
Profit before tax¥131m2021-04-01 → 2021-09-30Cons.Income before income taxes
Net income (owners)¥82m2022-04-01 → 2022-09-30Cons.Profit loss attributable to owners of parent
Net income (owners)¥340m2021-04-01 → 2022-03-31Cons.Profit loss attributable to owners of parent (5-year summary)
Net income (owners)¥113m2021-04-01 → 2021-09-30Cons.Profit loss attributable to owners of parent
Net income¥82m2022-04-01 → 2022-09-30Cons.Profit loss
Net income¥113m2021-04-01 → 2021-09-30Cons.Profit loss
Total assets¥4.4bnat 2022-09-30Cons.Assets
Total assets¥4.6bnat 2022-03-31Cons.Assets
Total assets¥4.1bnat 2021-09-30Cons.Total assets (5-year summary)
Total liabilities¥1.1bnat 2022-09-30Cons.Liabilities
Total liabilities¥1.4bnat 2022-03-31Cons.Liabilities
Net assets / equity¥3.3bnat 2022-09-30Cons.Net assets
Net assets / equity¥3.3bnat 2022-03-31Cons.Net assets
Net assets / equity¥3.0bnat 2021-09-30Cons.Net assets (5-year summary)
Cash and deposits¥1.9bnat 2022-09-30Cons.Cash and deposits
Cash and deposits¥2.2bnat 2022-03-31Cons.Cash and deposits
Cash & equivalents¥1.9bnat 2022-09-30Cons.Cash and cash equivalents
Cash & equivalents¥2.2bnat 2022-03-31Cons.Cash and cash equivalents
Cash & equivalents¥1.9bnat 2021-09-30Cons.Cash and cash equivalents
Cash & equivalents¥1.7bnat 2021-03-31dCons.Cash and cash equivalents
Operating cash flow−¥191m2022-04-01 → 2022-09-30Cons.Net cash provided by used in operating activities
Operating cash flow¥659m2021-04-01 → 2022-03-31Cons.Net cash provided by used in operating activities (5-year summary)
Operating cash flow¥295m2021-04-01 → 2021-09-30Cons.Net cash provided by used in operating activities
Investing cash flow−¥19m2022-04-01 → 2022-09-30Cons.Net cash provided by used in investment activities
Investing cash flow−¥66m2021-04-01 → 2022-03-31Cons.Net cash provided by used in investing activities (5-year summary)
Investing cash flow−¥37m2021-04-01 → 2021-09-30Cons.Net cash provided by used in investment activities
Financing cash flow−¥130m2022-04-01 → 2022-09-30Cons.Net cash provided by used in financing activities
Financing cash flow−¥72m2021-04-01 → 2022-03-31Cons.Net cash provided by used in financing activities (5-year summary)
Financing cash flow−¥66m2021-04-01 → 2021-09-30Cons.Net cash provided by used in financing activities
EPS (basic)¥60.112022-04-01 → 2022-09-30Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥73.992022-07-01 → 2022-09-30dCons.Basic earnings loss per share (5-year summary)
EPS (basic)¥248.752021-04-01 → 2022-03-31Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥82.612021-04-01 → 2021-09-30Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥802021-07-01 → 2021-09-30dCons.Basic earnings loss per share (5-year summary)
Equity ratio74.2%at 2022-09-30Cons.Equity to asset ratio (5-year summary)
Equity ratio70.4%at 2022-03-31Cons.Equity to asset ratio (5-year summary)
Equity ratio73.9%at 2021-09-30Cons.Equity to asset ratio (5-year summary)

Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.

Segments · 24
SegmentItemPeriodValue
jpcrp040300-q2r_E02021-000Healthcare Related Productsreportable segmentrevenue2022-04-01 → 2022-09-30¥556m
jpcrp040300-q2r_E02021-000Healthcare Related Productsreportable segmentrevenue external2022-04-01 → 2022-09-30¥556m
jpcrp040300-q2r_E02021-000Healthcare Related Productsreportable segmentsegment profit2022-04-01 → 2022-09-30¥48m
jpcrp040300-q2r_E02021-000Optical Applications And Special Customized Productsreportable segmentrevenue2022-04-01 → 2022-09-30¥335m
jpcrp040300-q2r_E02021-000Optical Applications And Special Customized Productsreportable segmentrevenue external2022-04-01 → 2022-09-30¥335m
jpcrp040300-q2r_E02021-000Optical Applications And Special Customized Productsreportable segmentsegment profit2022-04-01 → 2022-09-30¥103m
jpcrp040300-q2r_E02021-000X Ray Residual Stress Analyzerreportable segmentrevenue2022-04-01 → 2022-09-30¥288m
jpcrp040300-q2r_E02021-000X Ray Residual Stress Analyzerreportable segmentrevenue external2022-04-01 → 2022-09-30¥288m
jpcrp040300-q2r_E02021-000X Ray Residual Stress Analyzerreportable segmentsegment profit2022-04-01 → 2022-09-30¥84m
Total Of Reportable Segments And Otherssegment totalrevenue2022-04-01 → 2022-09-30¥1.2bn
Total Of Reportable Segments And Otherssegment totalrevenue external2022-04-01 → 2022-09-30¥1.2bn
Total Of Reportable Segments And Otherssegment totalsegment profit2022-04-01 → 2022-09-30¥234m
jpcrp040300-q2r_E02021-000Healthcare Related Productsreportable segmentrevenue2021-04-01 → 2021-09-30¥530m
jpcrp040300-q2r_E02021-000Healthcare Related Productsreportable segmentrevenue external2021-04-01 → 2021-09-30¥530m
jpcrp040300-q2r_E02021-000Healthcare Related Productsreportable segmentsegment profit2021-04-01 → 2021-09-30¥100m
jpcrp040300-q2r_E02021-000Optical Applications And Special Customized Productsreportable segmentrevenue2021-04-01 → 2021-09-30¥321m
jpcrp040300-q2r_E02021-000Optical Applications And Special Customized Productsreportable segmentrevenue external2021-04-01 → 2021-09-30¥321m
jpcrp040300-q2r_E02021-000Optical Applications And Special Customized Productsreportable segmentsegment profit2021-04-01 → 2021-09-30¥84m
jpcrp040300-q2r_E02021-000X Ray Residual Stress Analyzerreportable segmentrevenue2021-04-01 → 2021-09-30¥257m
jpcrp040300-q2r_E02021-000X Ray Residual Stress Analyzerreportable segmentrevenue external2021-04-01 → 2021-09-30¥257m
jpcrp040300-q2r_E02021-000X Ray Residual Stress Analyzerreportable segmentsegment profit2021-04-01 → 2021-09-30¥78m
Total Of Reportable Segments And Otherssegment totalrevenue2021-04-01 → 2021-09-30¥1.1bn
Total Of Reportable Segments And Otherssegment totalrevenue external2021-04-01 → 2021-09-30¥1.1bn
Total Of Reportable Segments And Otherssegment totalsegment profit2021-04-01 → 2021-09-30¥262m

Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.

All source rows · 420
ItemContextValueUnit
Number of shares heldCurrentQuarterInstant_No1MajorShareholdersMember115000
Shareholding ratioCurrentQuarterInstant_No1MajorShareholdersMember0.0841
Number of shares heldCurrentQuarterInstant_No2MajorShareholdersMember104000
Shareholding ratioCurrentQuarterInstant_No2MajorShareholdersMember0.0761
Number of shares heldCurrentQuarterInstant_No3MajorShareholdersMember51000
Shareholding ratioCurrentQuarterInstant_No3MajorShareholdersMember0.0375
Number of shares heldCurrentQuarterInstant_No4MajorShareholdersMember36000
Shareholding ratioCurrentQuarterInstant_No4MajorShareholdersMember0.0264
Number of shares heldCurrentQuarterInstant_No5MajorShareholdersMember33000
Shareholding ratioCurrentQuarterInstant_No5MajorShareholdersMember0.0245
Number of shares heldCurrentQuarterInstant_No6MajorShareholdersMember27000
Shareholding ratioCurrentQuarterInstant_No6MajorShareholdersMember0.0201
Number of shares heldCurrentQuarterInstant_No7MajorShareholdersMember27000
Shareholding ratioCurrentQuarterInstant_No7MajorShareholdersMember0.0198
Number of shares heldCurrentQuarterInstant_No8MajorShareholdersMember27000
Shareholding ratioCurrentQuarterInstant_No8MajorShareholdersMember0.0197
Number of shares heldCurrentQuarterInstant_No9MajorShareholdersMember26000
Shareholding ratioCurrentQuarterInstant_No9MajorShareholdersMember0.0192
Number of shares heldCurrentQuarterInstant_No10MajorShareholdersMember25000
Shareholding ratioCurrentQuarterInstant_No10MajorShareholdersMember0.0183
Number of shares heldCurrentQuarterInstant472000
Shareholding ratioCurrentQuarterInstant0.3456
Number of shares issued shares voting rightsCurrentQuarterInstant_SharesWithNoVotingRightsMember-
Number of shares issued shares voting rightsCurrentQuarterInstant_SharesWithRestrictedVotingRightsTreasurySharesEtcMember-
Number of shares issued shares voting rightsCurrentQuarterInstant_SharesWithRestrictedVotingRightsOtherMember-
Number of voting rights issued shares voting rightsCurrentQuarterInstant_SharesWithRestrictedVotingRightsOtherMember-
Number of shares issued shares voting rightsCurrentQuarterInstant_OrdinarySharesTreasurySharesSharesWithFullVotingRightsTreasurySharesEtcMember25100
Number of shares issued shares voting rightsCurrentQuarterInstant_OrdinarySharesSharesWithFullVotingRightsOtherMember1352600
Number of voting rights issued shares voting rightsCurrentQuarterInstant_OrdinarySharesSharesWithFullVotingRightsOtherMember13526
Number of shares issued shares voting rightsCurrentQuarterInstant_OrdinarySharesSharesLessThanOneUnitMember15759
Number of shares issued shares voting rightsCurrentQuarterInstant1393459
Number of voting rights issued shares voting rightsCurrentQuarterInstant13526
Number of shares held in own name treasury shares etcCurrentQuarterInstant_Row1Member25100
Number of shares held in others names treasury shares etcCurrentQuarterInstant_Row1Member-
Total number of shares held treasury shares etcCurrentQuarterInstant_Row1Member25100
Shareholding ratio treasury shares etcCurrentQuarterInstant_Row1Member0.0180
Number of shares held in own name treasury shares etcCurrentQuarterInstant25100
Number of shares held in others names treasury shares etcCurrentQuarterInstant-
Total number of shares held treasury shares etcCurrentQuarterInstant25100
Shareholding ratio treasury shares etcCurrentQuarterInstant0.0180
Cash and depositsPrior1YearInstant2212632000JPY
Cash and depositsCurrentQuarterInstant1884904000JPY
Notes and accounts receivable trade and contract assetsPrior1YearInstant681375000JPY
Notes and accounts receivable trade and contract assetsCurrentQuarterInstant780761000JPY
Work in processPrior1YearInstant421870000JPY
Work in processCurrentQuarterInstant379848000JPY
Raw materials and suppliesPrior1YearInstant168750000JPY
Raw materials and suppliesCurrentQuarterInstant209215000JPY
Other caPrior1YearInstant13169000JPY
Other caCurrentQuarterInstant13737000JPY

Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.

Data checks · 14 of 14 passed
balance sheet identityconsolidated 2022-03-31pass
balance sheet identityconsolidated 2022-09-30pass rounding
dei present pass
period resolution pass
statement vs summary · net assetsconsolidated 2022-03-31pass
statement vs summary · net assetsconsolidated 2022-09-30pass
statement vs summary · net income attributable to parentconsolidated 2021-04-01/2021-09-30pass
statement vs summary · net income attributable to parentconsolidated 2022-04-01/2022-09-30pass
statement vs summary · operating cash flowconsolidated 2021-04-01/2021-09-30pass
statement vs summary · operating cash flowconsolidated 2022-04-01/2022-09-30pass
statement vs summary · revenueconsolidated 2021-04-01/2021-09-30pass
statement vs summary · revenueconsolidated 2022-04-01/2022-09-30pass
statement vs summary · total assetsconsolidated 2022-03-31pass
statement vs summary · total assetsconsolidated 2022-09-30pass